Skip to main content
. Author manuscript; available in PMC: 2022 Aug 22.
Published in final edited form as: Psychother Psychosom. 2022 May 19;91(4):277–285. doi: 10.1159/000524628

Table 1.

Demographic and clinical characteristics of the randomized participants

Variable Immediate CBT (n = 40) Waitlist (n = 40)

Demographics
Age, mean (SD) 27.8 (9.9) 26.2 (9.5)
Sex at birth
 Female 92.5 (37) 75.0 (30)
 Male 7.5 (3) 25.0 (10)
Gender identity
 Female 90.0 (36) 75.0 (30)
 Male 7.5 (3) 25.0 (10)
 Genderqueer or non-binary 2.5 (1) 0.0 (0)
Hispanic ethnicitya 7.5 (3) 15.0 (6)
Race
 White 82.5 (33) 60.0 (24)
 Black 0.0 (0) 5.0 (2)
 Asian/Pacific Islander 10.0 (4) 20.0 (8)
 Other 7.5 (3) 15.0 (6)
Education
 ≤High school graduate 20.0 (8) 15.0 (6)
 Technical school/some college 27.5 (11) 27.5 (11)
 College graduate 27.5 (11) 27.5 (11)
 Graduate or professional school 25.0 (10) 30.0 (12)
Marital status
 Single, never married 75.0 (30) 70.0 (28)
 Married 17.5 (7) 17.5 (7)
 Living with partner 5.0 (2) 5.0 (2)
 Divorced/separated 2.5 (1) 7.5 (3)
Employment
 Full-time (≥35 h/week) 45.0 (18) 32.5 (13)
 Part-time (<35 h/week) 12.5 (5) 5.0 (2)
 Student 30.0 (12) 60.0 (24)
 Unemployed 5.0 (2) 0.0 (0)
 Homemaker 7.5 (3) 2.5 (1)

Clinical characteristics
Duration of BDD, years, mean (SD) 14.0 (9.9) 12.6 (11.6)
Number of body parts of concernc, mean (SD) 11.2 (6.3) 11.1 (6.4)
Delusional BDD 10.0 (4) 10.0 (4)
Primary body part of concernd
 Face 47.5 (19) 30.0 (12)
 Skin 37.5 (15) 25.0 (10)
 Nose 22.5 (9) 37.5 (15)
 Body build 22.5 (9) 15.0 (6)
 Hair 17.5 (7) 15.0 (6)
 Jaw 12.5 (5) 20.0 (8)
 Legs 15.0 (6) 7.5 (3)
 Weight 12.5 (5) 10.0 (4)
 Eyes 12.5 (5) 7.5 (3)
 Breasts 15.0 (6) 5.0 (2)
 Cheeks 5.0 (2) 12.5 (5)
 Butt 10.0 (4) 7.5 (3)
 Head 5.0 (2) 10.0 (4)
 Teeth 10.0 (4) 2.5 (1)
Current psychiatric comorbidities (DSM-5)d
 Social anxiety disorder 37.5 (15) 22.5 (9)
 Major depressive disorder/episode 27.5 (11) 25.0 (10)
 Generalized anxiety disorder 22.5 (9) 22.5 (9)
 Obsessive compulsive disorder 10.0 (4) 12.5 (5)
 Agoraphobia 10.0 (4) 10.0 (4)
 Post-traumatic stress disorder 2.5 (1) 10.0 (4)
 Other 12.5 (5) 12.5 (5)
Number of comorbid psychiatric disorders
 None 32.5 (13) 35.0 (14)
 1 35.0 (14) 35.0 (14)
 2 20.0 (8) 20.0 (8)
 3+ 12.5 (5) 10.0 (4)
Current psychotropic medicationd
 None 72.5 (29) 62.5 (25)
 Serotonin reuptake inhibitor 22.5 (9) 27.5 (11)
 Non-SRI antidepressant 5.0 (2) 5.0 (2)
 Antipsychotic 2.5 (1) 0.0 (0)
 Other psychotropic medicationb 10.0 (4) 20.0 (8)

Data are presented as % (n), except where indicated as mean (SD).

a

n = 1 missing (white race; ethnicity assumed to be non-Hispanic for calculations).

b

Includes benzodiazepines; anticonvulsants not included.

c

Body parts of concern include all parts of concern, not just body parts of primary concern.

d

Percentage sums may exceed 100% as participants could report more than one body part of primary concern, more than one diagnosis, or be on more than one stable psychotropic medication.